Sarah Romano - Chief Financial Officer at Entero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ENTO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sarah Romano - trading volume in the past year for Entero Therapeutics, Inc.

Holdings reported by Sarah Romano for Entero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 17.3K $11.1K $0.64 Jan 6, 2025 Direct

Transactions reported by Sarah Romano for Entero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.